Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study

BACKGROUND: Recently, two large randomized controlled trials which only included patients with underlying cardiovascular disease (CVD) or patients at high risk for CVD showed that two sodium glucose co-transporter 2 inhibitors (SGLT-2is) significantly reduced hospitalization for heart failure (hHF),...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young-Gun, Han, Seung Jin, Kim, Dae Jung, Lee, Kwan-Woo, Kim, Hae Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015464/
https://www.ncbi.nlm.nih.gov/pubmed/29935543
http://dx.doi.org/10.1186/s12933-018-0737-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015464/
https://www.ncbi.nlm.nih.gov/pubmed/29935543
http://dx.doi.org/10.1186/s12933-018-0737-5

Ejemplares similares